Section Review: Central & Peripheral Nervous Systems: Cholinergic channel modulators as a novel therapeutic strategy for Alzheimer's disease
- 1 January 1996
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 5 (1), 79-100
- https://doi.org/10.1517/13543784.5.1.79
Abstract
No abstract availableThis publication has 97 references indexed in Scilit:
- Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Functional Modulation of Human "Ganglionic-like" Neuronal Nicotinic Acetylcholine Receptors (nAChRs) by L-Type Calcium-Channel AntagonistsBiochemical and Biophysical Research Communications, 1995
- Neurochemical Evidence of Heterogeneity of Presynaptic and Somatodendritic Nicotinic Acetylcholine ReceptorsaAnnals of the New York Academy of Sciences, 1995
- Diversity of neuronal nicotinic acetylcholine receptors: Lessons from behavior and implications for cns therapeuticsLife Sciences, 1995
- Ligand—receptor interactions in the nicotinic acetylcholine receptor probed using multiple substitutions at conserved tyrosines on the α subunitFEBS Letters, 1994
- Cardiovascular effects of nicotine: Relation to deleterious effects of cigarette smokingAmerican Heart Journal, 1994
- The amino terminal half of the nicotinic β-subunit extracellular domain regulates the kinetics of inhibition by neuronal bungarotoxinProceedings Of The Royal Society B-Biological Sciences, 1993
- Pharmacologic Aspects of Cigarette Smoking and Nicotine AddictionNew England Journal of Medicine, 1988
- Cholinergic underactivity in human memory disordersLife Sciences, 1978
- Synthesis of a "bridged nicotine": 1,2,3,5,6,10b-hexahydropyrido[2,3-g]indolizineThe Journal of Organic Chemistry, 1978